Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page now states the study has 199 locations and removes several previously listed sites. The eligibility language is refined to specify TP53 wild-type status by central NGS for histologically confirmed endometrial cancer.
    Difference
    0.5%
    Check dated 2026-08-30T21:54:41.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page's revision metadata updated from v3.6.4 to v3.6.5, indicating a newer build of the page. No study data or visible content appears to be affected.
    Difference
    0.0%
    Check dated 2026-08-09T11:11:19.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    A new page revision tag indicates the study page was updated from version v3.6.3 to v3.6.4. This appears to be a minor metadata update rather than a substantive change to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T17:16:40.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Revision: v3.6.3 was recorded in the page history, replacing v3.6.2. This is a minor version update and does not change the study details or user-visible content.
    Difference
    0.0%
    Check dated 2026-07-04T05:18:19.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The revision history now displays v3.6.2 as the current page version, replacing the previous v3.6.0. This indicates the page content has been refreshed to a newer version.
    Difference
    0.0%
    Check dated 2026-06-27T03:10:38.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The study page now notes that recruitment is closed and no longer accepting participants.
    Difference
    0.2%
    Check dated 2026-06-12T16:31:19.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.